Filing Details

Accession Number:
0001493152-21-004592
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-23 16:05:31
Reporting Period:
2021-02-19
Accepted Time:
2021-02-23 16:05:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318306 Abeona Therapeutics Inc. ABEO Pharmaceutical Preparations (2834) 830221517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1642715 Todd Wider 1330 Avenue Of The Americas, 33Rd Floor
New York NY 10019
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-19 251,625 $2.39 25,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.371 to $2.402, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote.